CDK4 and breast carcinoma: As breast cancer biopsies were sequenced, it became apparent that a significant proportion of patient samples exhibited dysregulation of the CDK4/cyclin D1/Rb interaction with overexpression/amplification of cyclin D1 (CCND1) and alterations in p16 [34,35].